share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Vachon Mark

SEC ·  Nov 9 05:14

Summary by Futu AI

On November 6, 2024, Mark Vachon, associated with bluebird bio, Inc. [BLUE], was granted 24,900 shares of common stock at no cost. This transaction, which was completed on the same day, increased Vachon's direct holdings in the company to a total of 49,941 shares. The grant is part of the company's stock-based compensation program and reflects a direct ownership interest in the securities.
On November 6, 2024, Mark Vachon, associated with bluebird bio, Inc. [BLUE], was granted 24,900 shares of common stock at no cost. This transaction, which was completed on the same day, increased Vachon's direct holdings in the company to a total of 49,941 shares. The grant is part of the company's stock-based compensation program and reflects a direct ownership interest in the securities.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated